Determination of captopril in human serum by high performance liquid chromatography using solid-phase extraction

被引:52
作者
Bahmaei, M
Khosravi, A
Zamiri, C
Massoumi, A
Mahmoudian, M
机构
[1] DAROUPAKHSH PHARMACEUT CO, PHARMACEUT RES CTR, TEHRAN, IRAN
[2] SHAHID BEHESHTI UNIV, DEPT CHEM, TEHRAN, IRAN
关键词
captopril; reverse phase chromatography; solid phase extraction; p-bromophenacyl bromide; thiosalicylic acid; PHARMACOLOGICAL PROPERTIES; THERAPEUTIC EFFICACY; BIOLOGICAL-FLUIDS; PLASMA; BLOOD;
D O I
10.1016/S0731-7085(96)01915-2
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
A rapid, simple and sensitive assay was developed for determination of captopril in human serum. We employed silica gel cartridge for efficient extraction of captopril adduct from human serum. Captopril was trapped with p-bromophenacyl bromide (pBPB) to give captopril-pBPB adduct. A 4-ml benzene extract of 1 ml acidified serum was passed through 1 ml silica gel cartridge. Potential interfering compounds were removed with 4-ml benzene wash. The captopril-pBPB adduct was eluted with 0.5 ml acetonitrile. Of this acetonitrile solution (100 mu l) was injected on an ODS reverse phase HPLC column (chromatography conditions; mobile phase; acetonitrile-water-acetic acid (225:270:5, v/v/v), flow rate; 1 ml min(-1), detection; UV at 263 nm). It is found that this method is accurate and does not require time consuming evaporation-concentration steps. Recovery exceeds 94% and analytical responses are linear over captopril concentration range from 50 up to 1000 ng ml(-1). The coefficients of variation from 108 ng ml(-1) to 605 ng ml(-1) varied between 3.7-7.7% and the relative error did not exceed 3.7%. Therefore, this method can be used for routine clinical monitoring and in pharmacokinetic studies of captopril. (C) 1997 Elsevier Science B.V.
引用
收藏
页码:1181 / 1186
页数:6
相关论文
共 16 条
[1]   PHARMACOKINETICS OF CAPTOPRIL IN HEALTHY-SUBJECTS AND IN PATIENTS WITH CARDIOVASCULAR-DISEASES [J].
DUCHIN, KL ;
MCKINSTRY, DN ;
COHEN, AI ;
MIGDALOF, BH .
CLINICAL PHARMACOKINETICS, 1988, 14 (04) :241-259
[2]   GAS CHROMATOGRAPHY-SELECTED ION MONITORING MASS-SPECTROMETRIC DETERMINATION OF CAPTOPRIL IN HUMAN-BLOOD [J].
FUNKE, PT ;
IVASHKIV, E ;
MALLEY, MF ;
COHEN, AI .
ANALYTICAL CHEMISTRY, 1980, 52 (07) :1086-1089
[3]  
GUIDICELLI JF, 1984, BR J CLIN PHARM, V18, P749
[4]   DETERMINATION OF CAPTOPRIL AND ITS MIXED DISULFIDES IN PLASMA AND URINE BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
HAYASHI, K ;
MIYAMOTO, M ;
SEKINE, Y .
JOURNAL OF CHROMATOGRAPHY, 1985, 338 (01) :161-169
[5]   CAPTOPRIL - A PRELIMINARY REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC EFFICACY [J].
HEEL, RC ;
BROGDEN, RN ;
SPEIGHT, TM ;
AVERY, GS .
DRUGS, 1980, 20 (06) :409-452
[6]   HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ANALYSIS OF CAPTOPRIL IN PLASMA [J].
JARROTT, B ;
ANDERSON, A ;
HOOPER, R ;
LOUIS, WJ .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1981, 70 (06) :665-667
[7]  
KAWAHARA Y, 1981, CHEM PHARM BULL, V29, P150
[8]   SIMPLE MEASUREMENT OF CAPTOPRIL IN PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH ULTRAVIOLET DETECTION [J].
KLEIN, J ;
COLIN, P ;
SCHERER, E ;
LEVY, M ;
KOREN, G .
THERAPEUTIC DRUG MONITORING, 1990, 12 (01) :105-110
[9]   DISPOSITION OF CAPTOPRIL IN NORMAL SUBJECTS [J].
KRIPALANI, KJ ;
MCKINSTRY, DN ;
SINGHVI, SM ;
WILLARD, DA ;
VUKOVICH, RA ;
MIGDALOF, BH .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 27 (05) :636-641
[10]  
LANGLEY, 1941, ORG SYN COLL, V1, P127